Presepsin values and prognostic nutritional index predict mortality in intensive care unit patients with sepsis: a pilot study

[1] Singer M(2016)The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA 315 801-810

[2] Deutschman CS(2006)Sepsis occurrence in acutely ill patients investigators, sepsis in european intensive care units: results of the SOAP study Crit Care Med 34 344-353

[3] Seymour CW(2013)Severe sepsis and septic shock N Engl J Med 369 840-851

[4] Shankar-Hari M(2013)Surviving sepsis campaign guidelines committee including the pediatric subgroup: surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock 2012 Crit Care Med 41 580-637

[5] Annane D(2010)Sepsis biomarkers: a review Crit Care 14 R15-435

[6] Bauer M(2013)Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis Lancet Infect Dis 13 426-40

[7] Vincent JL(2011)Diagnostic and prognostic biomarkers of sepsis in critical care J Antimicrob Chemother 66 ii33-939

[8] Sakr Y(2011)Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients Clin Chem Lab Med 49 937-769

[9] Sprung CL(2011)Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome J Infect Chemother 17 764-897

[10] Ranieri VM(2014)Diagnostic and prognostic utility of soluble CD14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment Crit Care 18 507-2161

[1] Singer M(2016)The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA 315 801-810

[2] Deutschman CS(2006)Sepsis occurrence in acutely ill patients investigators, sepsis in european intensive care units: results of the SOAP study Crit Care Med 34 344-353

[3] Seymour CW(2013)Severe sepsis and septic shock N Engl J Med 369 840-851

[4] Shankar-Hari M(2013)Surviving sepsis campaign guidelines committee including the pediatric subgroup: surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock 2012 Crit Care Med 41 580-637

[5] Annane D(2010)Sepsis biomarkers: a review Crit Care 14 R15-435

[6] Bauer M(2013)Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis Lancet Infect Dis 13 426-40

[7] Vincent JL(2011)Diagnostic and prognostic biomarkers of sepsis in critical care J Antimicrob Chemother 66 ii33-939

[8] Sakr Y(2011)Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients Clin Chem Lab Med 49 937-769

[9] Sprung CL(2011)Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome J Infect Chemother 17 764-897

[10] Ranieri VM(2014)Diagnostic and prognostic utility of soluble CD14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment Crit Care 18 507-2161